Loading clinical trials...
Loading clinical trials...
Multi-center Comparative Effectiveness Randomized Trial to Assess a Transseptal Approach to Left Ventricular Ablation Compared to Retrograde to Prevent Cerebral Emboli & Neurocognitive Decline in Adults With Ventricular Tachycardia/Premature Ventricular Contractions
Conditions
Interventions
Transseptal Aortic Approach Catheter Ablation Procedure
Retrograde Aortic Approach Catheter Ablation Procedure
Locations
21
United States
Banner - University Medical Center
Phoenix, Arizona, United States
Cedars Sinai Medical Center
Los Angeles, California, United States
University of California, Los Angeles
Los Angeles, California, United States
Stanford University
Palo Alto, California, United States
University of California, San Diego
San Diego, California, United States
San Francisco Veterans Affairs (SFVA) Health Care
San Francisco, California, United States
Start Date
July 2, 2019
Primary Completion Date
November 25, 2023
Completion Date
November 25, 2023
Last Updated
December 26, 2023
NCT05367245
NCT05077748
NCT04925453
NCT06224088
NCT04647656
NCT04007939
Lead Sponsor
University of California, San Francisco
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions